台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
  • 股價
    90.3
  • 漲跌
    ▲0.4
  • 漲幅
    +0.44%
  • 成交量
    308
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智擎 (4162)籌碼相關-凱基-大安 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0805/1805/2803/2004/0104/1404/2405/0605/30708090100110Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

凱基-大安 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/1300.00790.7989.80-71,266-0.55%
2025/05/12790.6400.0090.6071,2980.54%
2025/05/0500.00186.2087.70-11,764-0.06%
2025/04/30191.0000.0089.2011,7960.06%
2025/03/1900.002105.50104.50-21,718-0.12%
2025/03/170107.002106.00105.00-21,714-0.12%
2025/03/131106.0000.00103.5011,7070.06%
2025/03/1200.001107.50107.00-11,695-0.06%
2025/03/1100.001105.50107.00-11,697-0.06%
2025/03/071107.5000.00107.5011,6650.06%
2025/03/051114.5000.00115.5011,6450.06%
2025/02/272114.7500.00109.0021,5680.13%
2025/02/261115.002117.25115.50-11,553-0.06%
2025/02/2500.002113.00113.00-21,443-0.14%
2025/02/241113.5000.00115.0011,4310.07%
2025/02/182110.7500.00110.0021,4010.14%
2025/02/111110.0000.00109.0011,3920.07%
2025/02/0700.001120.00120.50-11,351-0.07%
2025/02/061118.5000.00119.0011,3290.08%
2025/01/13196.7000.0096.3011,3700.07%
2025/01/061101.50199.20101.5001,2590.00%
2024/12/25187.7000.0091.0011,2140.08%
2024/12/0600.00193.7093.30-11,180-0.08%
2024/12/0400.00295.1094.60-21,164-0.17%
2024/12/0300.00494.6394.40-41,161-0.34%
2024/11/2600.00194.4094.00-11,084-0.09%
2024/11/22195.1000.0093.8011,0310.10%
2024/11/19297.7000.0096.0021,0150.20%
2024/11/156101.751102.5099.9059890.51%
2024/11/1400.001102.00101.50-1971-0.10%
2024/11/133107.832106.25106.5019460.11%
2024/11/126104.0010101.31104.00-4916-0.44%
2024/11/051106.5000.00106.0017820.13%
2024/11/0100.001107.00105.00-1730-0.14%
2024/09/1800.00183.6082.90-1633-0.16%
2024/09/11182.9000.0082.1016560.15%
2024/09/05183.8000.0082.1016890.15%
2024/08/23185.6000.0085.9017400.14%
2024/08/20386.3000.0085.8037420.40%
2024/08/0700.00185.8086.70-1794-0.13%
2024/08/0500.00183.1083.00-1764-0.13%
2024/07/29195.5000.0094.5017360.14%
2024/07/2600.00296.8097.60-2729-0.27%
2024/07/22294.50191.6092.0017180.14%
2024/07/18199.0000.0099.4016760.15%
2024/07/1500.00197.5098.40-1663-0.15%
2024/07/11195.2000.0095.2016500.15%
2024/07/0800.003100.50100.50-3655-0.46%
2024/06/27198.2000.0095.7015820.17%
2024/06/26497.0000.0097.6045760.69%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章